Dr Reddy's gets Brazil approval for generic semaglutide
In short
Dr Reddy's Laboratories won Brazil approval for a generic semaglutide injection.
The drug is for adults with type 2 diabetes.
What the reporting says
Dr Reddy's Laboratories received Brazil regulator approval for a generic semaglutide injection, according to the publisher summaries. The medicine is used for adults with insufficiently controlled type 2 diabetes, and BusinessLine said the company plans to launch it with Aché in a $244.6 million market.
Why it matters
Dr Reddy's Laboratories received Brazil regulatory approval for a generic semaglutide injection. The summaries say the treatment is for adults with insufficiently controlled type 2 diabetes, and that the company plans a launch with Aché in a $244.6 million market.